The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma

von Figura, Guido, Fukuda, Akihisa, Roy, Nilotpal, Liku, Muluye E., Morris IV, John P., Kim, Grace E., Russ, Holger A., Firpo, Matthew A. +7 more·2014·Nature Cell Biology
DOI 10.1038/ncb2916

Cited by (190)

Items 101–190 of 190

  1. Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway
    Osamu Araki, Motoyuki Tsuda, Mayuki Omatsu, Mio Namikawa, Makoto Sono, Yuichi Fukunaga, Tomonori Masuda, Takaaki Yoshikawa, Munemasa Nagao, Satoshi Ogawa et al. · 2023 · Oncogene
  2. A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics
    Ozhan Ocal, V. Pashkov, R. Kollipara, Yalda Zolghadri, V. H. Cruz, Michael A. Hale, Blake R. Heath, A. Artyukhin, A. Christie, P. Tsoulfas et al. · 2015 · Disease Models & Mechanisms
  3. Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Review of Their Genetic Characteristics and Mouse Models
    Jin Li, T. Wei, Jian Zhang, T. Liang · 2021 · Cancers
  4. Biophysical insights into glucose-dependent transcriptional regulation by PDX1
    E. Usher, S. Showalter · 2022 · Journal of Biological Chemistry
  5. Epithelial Nr5a2 heterozygosity cooperates with mutant Kras in the development of pancreatic cystic lesions
    Isidoro Cobo, M. Iglesias, M. Flández, C. Verbeke, N. Pozo, M. Llorente, R. Lawlor, C. Luchini, B. Rusev, A. Scarpa et al. · 2020 · Journal of Pathology
  6. Differentiation and Inflammation: ‘Best Enemies’ in Gastrointestinal Carcinogenesis
    Nathan M. Krah, Lewis Charles Murtaugh · 2016 · Trends in cancer
  7. Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic
    Yolanda Rodrı́guez Gil, Paula Jiménez Sánchez, Raúl Muñoz Velasco, Ana García García, Victor Javier Sanchez-Arevalo Lobo · 2021 · International Journal of Molecular Sciences
  8. Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer
    Jiangang Zhao, Jiahui Li, Hans Schlößer, Felix Popp, Marie Christine Popp, Hakan Alakus, Karl‐Walter Jauch, Christiane J. Bruns, Yue Zhao · 2017 · Stem Cells International
  9. TrxG Complex Catalytic and Non-catalytic Activity Play Distinct Roles in Pancreas Progenitor Specification and Differentiation
    Stephanie A. Campbell, Cassandra L. McDonald, Nicole A. J. Krentz, Francis C. Lynn, Brad G. Hoffman · 2019 · Cell Reports
  10. Stem Cells in the Exocrine Pancreas during Homeostasis, Injury, and Cancer
    Sophie C. Lodestijn, Sanne M. van Neerven, Louis Vermeulen, Maarten F. Bijlsma · 2021 · Cancers
  11. The Sag-Shoc2 axis regulates conversion of mPanINs to cystic lesions in Kras pancreatic tumor model
    Mingjia Tan, Yu Chang, Xiaoqiang Liu, Hua Li, Zaiming Tang, Mukesh Kumar Nyati, Yi Sun · 2022 · Cell Reports
  12. Whole Genome Expression Profiling Shows that BRG1 Transcriptionally Regulates UV Inducible Genes and Other Novel Targets in Human Cells
    Ling Zhang, Leah Nemzow, Hua Chen, Jennifer J. Hu, Feng Gong · 2014 · PLoS ONE
  13. Polybromo 1/vimentin axis dictates tumor grade, epithelial-mesenchymal transition, and metastasis in pancreatic cancer
    Munenori Kawai, A. Fukuda, Munehiro Ikeda, Kei Iimori, Kenta Mizukoshi, Kosuke Iwane, Go Yamakawa, Mayuki Omatsu, Mio Namikawa, M. Sono et al. · 2025 · Journal of Clinical Investigation
  14. Malignant, but not benign, intraductal papillary mucinous neoplasm preferentially associates with prior extrapancreatic malignancies
    Takaharu Kato, Sergio Alonso, Hiroshi Noda, Yasuyuki Miyakura, Shingo Tsujinaka, Masaaki Saito, Yuta Muto, Taro Fukui, Kosuke Ichida, Yuji Takayama et al. · 2016 · Oncology Reports
  15. Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts
    Dietrich Alexander Ruess, Kıvanç Görgülü, Sonja M. Wörmann, Hana Algül · 2017 · Drugs & Aging
  16. Sex- and Co-Mutation-Dependent Prognosis in Patients with SMARCA4-Mutated Malignancies
    Minggui Pan, Chen Jiang, Zheyang Zhang, Ninah S. Achacoso, Aleyda V. Solorzano, Pam Tse, Elaine H. Chung, Jennifer Marie Suga, Sachdev P. Thomas, Laurel A. Habel · 2023 · Cancers
  17. Atypical flat lesions derive from pancreatic acinar cells
    Guido von Figura, Leonie Fahrenkrog-Petersen, Ana Hidalgo‐Sastre, Daniel Hartmann, Norbert Hüser, Roland Michael Schmid, Matthias Hebrok, Nilotpal Roy, Iréne Esposito · 2017 · Pancreatology
  18. Brg1 is required to maintain colorectal cancer stem cells
    Takaaki Yoshikawa, Akihisa Fukuda, Mayuki Omatsu, Mio Namikawa, Makoto Sono, Yuichi Fukunaga, Tomonori Masuda, Osamu Araki, Munemasa Nagao, Satoshi Ogawa et al. · 2021 · The Journal of Pathology
  19. Inactivation of the Euchromatic Histone-Lysine N-Methyltransferase 2 Pathway in Pancreatic Epithelial Cells Antagonizes Cancer Initiation and Pancreatitis-Associated Promotion by Altering Growth and Immune Gene Expression Networks
    Guillermo Urrutia, Thiago M. de Assuncao, Angela Mathison, Ann Salmonson, Romica Kerketta, Atefeh Zeighami, Timothy J. Stodola, Volkan N. Adsay, Burçin Pehlivanoğlu, Michael B. Dwinell et al. · 2021 · Frontiers in Cell and Developmental Biology
  20. Leveraging Mechanisms Governing Pancreatic Tumorigenesis To Reduce Pancreatic Cancer Mortality
    Timothy R. Donahue, David W. Dawson · 2016 · Trends in Endocrinology and Metabolism
  21. The Use of Genetically Engineered Mouse Models for Studying the Function of Mutated Driver Genes in Pancreatic Cancer
    Ching‐Chieh Weng, Yu‐Chun Lin, Kuang‐Hung Cheng · 2019 · Journal of Clinical Medicine
  22. Current methods in mouse models of pancreatic cancer.
    P. Mazur, A. Herner, Florian Neff, J. Siveke · 2015 · Methods in molecular biology
  23. Epigenetic regulator ARID1A and stem cell transcription factor SOX9 in the maintenance of pancreatic ductal cell differentiation state and development of intraductal papillary mucinous neoplasia (IPMN) and pancreatic ductal adenocarcinoma (PDAC)
    Naipeng Cui, Jinsong Zhang, Huatian Huang, Lingeng Lu · 2018 · Translational Cancer Research
  24. Epigenetic reprogramming in pancreatic premalignancy and clinical implications
    Wei Zhang, Tingting Jiang, Keping Xie · 2023 · Frontiers in Oncology
  25. Loss of Jag1 cooperates with oncogenic Kras to induce pancreatic cystic neoplasms
    Wen-Cheng Chung, Lavanya Challagundla, Yunyun Zhou, Min Li, Azeddine Atfi, Keli Xu · 2020 · Life Science Alliance
  26. SWI/SNF-deficient cancers of the Gastroenteropancreatic tract: an in-depth review of the literature and pathology
    Klaudia M. Nowak, Runjan Chetty · 2020 · Seminars in Diagnostic Pathology
  27. NFATc1 Is a Central Mediator of EGFR-Induced ARID1A Chromatin Dissociation During Acinar Cell Reprogramming
    Zhe Zhang, Xin Wang, Feda H. Hamdan, Anna Likhobabina, Shilpa Patil, Lena Aperdannier, Madhobi Sen, Jacobe Traub, Albrecht Neeße, André Fischer et al. · 2023 · Cellular and Molecular Gastroenterology and Hepatology
  28. Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma
    Akihisa Fukuda · 2015 · Journal of Hepato-Biliary-Pancreatic Sciences
  29. Clinical significance of pancreatic ductal metaplasia
    Tingting Jiang, Wei Fang, Keping Xie · 2022 · The Journal of Pathology
  30. Clinical and Molecular Attributes and Evaluation of Pancreatic Cystic Neoplasm
    Pratima Raut, Rama Krishna Nimmakayala, Surinder K. Batra, Moorthy Palanimuthu Ponnusamy · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  31. Cell of Origin of Pancreatic cancer
    Chenlei Zheng, Jianing Wang, Junli Wang, Qi Zhang, Tingbo Liang · 2024 · Pancreas
  32. Cell Type of Pancreatic Ductal Adenocarcinoma Origin: Implications for Prognosis and Clinical Outcomes
    Shilpa Patil, Yan Dou, Janel L. Kopp · 2021 · Visceral Medicine
  33. SWItch/Sucrose Nonfermentable complex-deficient pulmonary neoplasms: clinicopathologic characteristics and outcomes to radiotherapy and immunotherapy
    Yu Lan Gu, Songtao Lai, Juan Yang, Junhua Zhang, Xingwen Fan, Qiang Zheng · 2024 · Translational Lung Cancer Research
  34. Molecular signaling in pancreatic ductal metaplasia: emerging biomarkers for detection and intervention of early pancreatic cancer
    Xiaojia Li, Jie He, Keping Xie · 2022 · Cellular Oncology
  35. The Molecular Pathology of Precursor Lesions of Pancreatic Cancer
    Aatur Dilip Singhi, Anirban Maitra · 2018 · Springer eBooks
  36. Genomic alterations in pancreatic cystic neoplasms: from molecular characterization to precision clinical management
    Sen Yang, Tianqi Chen, Ming Cui, Ya Nan Hu · 2025 · International Journal of Surgery
  37. Advances in pancreatic cancer epigenetics: From the mechanism to the clinic
    Jia-Dan Zhou, Hongzhang Shen · 2025 · World Journal of Gastrointestinal Oncology
  38. NF2 loss malignantly transforms human pancreatic acinar cells and enhances cell fitness under environmental stress
    Yi Xu, Michael H Nipper, Angel A. Dominguez, Chenhui He, Francis E. Sharkey, Sajid Khan, Han Xu, Daohong Zhou, Lei Zheng, Yu Luan et al. · 2026 · Journal of Clinical Investigation
  39. Acvr1b Loss Increases Formation of Pancreatic Precancerous Lesions From Acinar and Ductal Cells of Origin
    Kiyoshi Saeki, Ian S. Wood, Wei Wang, Shilpa Patil, Yanping Sun, David F. Schaeffer, Gloria H. Su, Janel L. Kopp · 2024 · Cellular and Molecular Gastroenterology and Hepatology
  40. SMARCA4 supports the oncogenic landscape of KRAS -driven lung tumors
    Shivani Malik, Masaya Oshima, Nilotpal Roy, Swati Kaushik, Ora Kuvshinova, Wei Wu, John E. Greer, Shon Green, Martin McMahon, Kuang‐Yu Jen et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  41. Single-cell transcriptomics reveal the prognostic roles of epithelial and T cells and DNA methylation-based prognostic models in pancreatic cancer
    Jing Du, Yaqian Zhao, Jie Dong, Peng Li, Yan Hu, Hailang Fan, Feifan Zhang, Lanlan Sun, Dake Zhang, Yuhua Zhang · 2024 · Clinical Epigenetics
  42. The cis‐regulatory switchboard of pancreatic ductal cancer
    Jorge P. Ferrer, Francisco X. Real · 2016 · The EMBO Journal
  43. Epigenetics of gastrointestinal diseases: notes from a workshop
    David L. Marks, Rachel Olson, Raul A. Urrutia, Daniel D. Billadeau, Nilotpal Roy, George A. Călin, Muller Fabbri, Μαρίνα Κουτσιούμπα, Dimitrios Iliopoulos, Tamás Ördög et al. · 2018 · Epigenetics
  44. Genetically altered cancer epigenome
    Ming Tang, Huacheng Luo, Jianrong Lu · 2015 · Elsevier eBooks
  45. Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma
    Joyce K. Thompson, Filip Bednar · 2021 · Epigenomes
  46. Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas: current understanding and perspectives on malignant progression
    Yuki Makino, Kohki Oyama, Akiko Sagara, Fredrik I. Thege, Anirban Maitra · 2025 · Journal of Gastroenterology
  47. Epigenetic and transcriptional control of classical and basal-like cell states in pancreatic ductal adenocarcinoma
    Christina Parassiadis, Steven A. Johnsen · 2026 · Gastroenterology report
  48. Liver and Pancreas
    M.L. Dagli, Lucas Martins Chaible, Katja Steiger · 2021
  49. Cystic tumor ablation with different concentrations of lauromacrogol solution in an animal model
    Fei Gao, Huikai Li, Xiuxue Feng, Chen DU, Ke Han, Ningli Chai, Enqiang Linghu · 2023 · Minerva Gastroenterology
  50. Chromatin Remodeling and Epigenetic Reprogramming in Chronic Disease and Cancer in the Liver and Pancreas
    Maite G. Fernández‐Barrena, Christopher L. Pin · 2016 · Elsevier eBooks
  51. SOX9 as One of the Central Units of Regulation Axis of Pancreas Embryogenesis and Cancer Progression
    S. Bulanenkova, E. Snezhkov, S. B. Akopov · 2019 · Molecular Genetics Microbiology and Virology
  52. Epigenetic Mechanisms in Liver and Pancreas Generation and Regeneration
    Dario Nicetto, Ryan L. McCarthy, Kenneth S. Zaret · 2019 · Elsevier eBooks
  53. Recent Advances in Chromatin Mechanisms Controlling Pancreatic Carcinogenesis
    Thomas P. Hank, Andrew Scott Liss · 2018 · Epigenomes
  54. Developmental Molecular Biology of the Pancreas
    Lewis Charles Murtaugh, Ondine B. Cleaver, Raymond J. MacDonald · 2016 · Springer eBooks
  55. New Insights Into Plasticity of Pancreatic Cancer
    Jennifer M. Bailey, Audrey M. Hendley, Anirban Maitra · 2015 · Pancreas
  56. Molecular mechanisms of RACK1-driven metastasis in pancreatic ductal adenocarcinoma revealed by single-cell RNA sequencing
    Hangyu Liu, Tingxin Wang, Yuying Cui, Biao Zhang, Dong Shang, Huiyi Song · 2025 · Discover Oncology
  57. Out of the niche: exploring unknown pathways
    Kateri Ann Moore, Giulio Cossu · 2014 · Development
  58. Pancreatic Carcinogenesis
    Valentin Taucher, Johannes Haybaeck · 2017 · Springer eBooks
  59. Spotlight on BRG1
    Nicola Jane McCarthy · 2014 · Nature reviews. Cancer
  60. Pancreatic plasticity: epigenetic mechanisms and connections to neoplasia
    Charles J. David · 2019 · Journal of Pancreatology
  61. Promoter-Level Transcriptome Identifies Stemness Associated With Relatively High Proliferation in Pancreatic Cancer Cells
    Ru Chen, Aiko Sugiyama, Naoyuki Kataoka, Masahiro Sugimoto, Shoko Yokoyama, Akihisa Fukuda, Shigeo Takaishi, Hiroshi Seno · 2020 · Frontiers in Oncology
  62. Novel Biomarkers of Invasive IPMN
    Stephen Hasak, Koushik K. Das · 2020 · Molecular and translational medicine
  63. Single-cell analysis of ductal differentiation
    Jason Robert Pitarresi, Anil K. Rustgi · 2021 · Nature Biomedical Engineering
  64. The Role of ARID1A in Oncogenic Transcriptional (de)Regulation in Colorectal Cancer
    Madhobi Sen · 2019
  65. nSMase2-mediated exosome secretion shapes the tumor microenvironment to immunologically support pancreatic cancer
    Audrey M. Hendley, Sudipta Ashe, Atsushi Urano, Martin Ng, Tuan Anh Phu, Xianlu L. Peng, Changfei Luan, Anna‐Marie Finger, Gun Ho Jang, Natanya R. Kerper et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Epigenome modifying enzymes regulate development and progression of pancreatic cancers
    Keisuke Tateishi, Keisuke Yamamoto, Kazuhiko Koike · 2016 · Suizo
  67. Development of a genetically engineered mouse model of intraductal papillary mucinous neoplasm of the pancreas with the conditional expression of GNASR201H
    Toru Furukawa, Katsunobu Taki, Masaki Ohmuraya · 2016 · Suizo
  68. Molecular Analysis for Therapeutic Targets of Pancreatic Cancer
    Shinji Tanaka · 2017 · Current human cell research and applications
  69. Targeting the epigenome as a therapeutic strategy for pancreatic tumors
    Sathish Kumar Mungamuri · 2019 · Elsevier eBooks
  70. SOX9 как одно из центральных звеньев оси регуляции эмбрионального развития и прогрессии рака поджелудочной железы
    С. C. Буланенкова, Е. В. Снежков, Сергій Акопов · 2019 · Molecular Genetics Microbiology and Virology (Russian)
  71. Nuclear GSK-3β and Oncogenic KRas Promote Expansion of Terminal Duct Cells and the Development of Intraductal Papillary Mucinous Neoplasm
    Ding Li, Kaely Roeck, Cheng Zhang, Brooke Zidek, Esther P. B. Rodman, Yasmin Genevieve Hernandez-Barco, Jin‐San Zhang, William R. Bamlet, Ann L. Oberg, Lizhi Zhang et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  72. Gene modules and non-coding RNAs involved in pancreatic tumorigenesis through acinar ductal metaplasia
    Huairong Zhang, Bingyin Shi, Zu‐Hua Gao, Bo Gao · 2020
  73. Gene modules and non-coding RNAs involved in pancreatic tumorigenesis through acinar ductal metaplasia
    Huairong Zhang, Bingyin Shi, Zu‐Hua Gao, BO GAO · 2020
  74. Faculty Opinions recommendation of Regulation of epithelial plasticity determines metastatic organotropism in pancreatic cancer.
    Beatriz Sosa‐Pineda · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  75. The Molecular Pathology of Precursor Lesions of Pancreatic Cancer
    Aatur Dilip Singhi, Anirban Maitra · 2017 · Springer eBooks
  76. Molecular Biology of Pancreatic Cancer
    Yoshiaki Sunami, Ibrahim Büdeyri, Johanna Häußler, Christoph W. Michalski, Jorg H. Kleeff · 2022
  77. Acvr1b loss increases formation of pancreatic precancerous lesions from acinar and ductal cells of origin
    Kiyoshi Saeki, Ian S. Wood, Wei Chuan K. Wang, Shilpa Patil, Yanping Sun, David F. Schaeffer, Gloria H. Su, Janel L. Kopp · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  78. BAZ2A-SUV39H1-SMAD2/3-OCT4 regulates stemness, cell cycle exit and chemoresistance in pancreatic ductal adenocarcinoma
    Stefania Militi, Feng Liu, Reshma Nibhani, Mai Abdel Mouti, Martin Pook, Liuyang Cai, Siew Woh Choo, Siim Pauklin · 2023 · Research Square
  79. Quantitative secretomics identifies ligand-receptor pairs in pancreatic cancer that mediate bidirectional crosstalk between cancer stem cells and nociceptors
    Chao‐Hui Chang, Feng Liu, Siwei Deng, Stefania Militi, Svenja S. Hester, Aniko Rendek, Zahir F. Soonawalla, Wei Chieh Huang, Román Fischer, Siim Pauklin · 2024 · Research Square
  80. Case report: Aggressive NSCLC with partial BRG-1 deficiency and KRAS G12C mutation: a case study and treatment challenges
    Chengwei Jin, Hong Ge, Dongsheng Hou, Jing Li, Mingming Tan · 2024 · Frontiers in Oncology
  81. Identification and Implications for Tumor Heterogeneity of a DNA Methylation-Based Signature Classifying Pancreatic Ductal Adenocarcinoma Based on their Cellular Origin
    Ilianna Zoi, Memoona Rajput, Adrián Holguín-Horcajo, Malak Haidar, Davide Brusa, Ken Chu, Jane Xie, Mario A. Shields, Sofia Ferreira, Ben Z. Stanger et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  82. Loss of Brg1 and Pten in Pancreatic Ductal Cells Forms Intraductal Tubulopapillary Neoplasm via the YAP/TAZ Pathway
    Kei Iimori, A. Fukuda, M. Nagao, S. Matsuyama, Munehiro Ikeda, Yoko Masui, Shinnosuke Nakayama, Naoki Aoyama, Kenta Mizukoshi, Munenori Kawai et al. · 2025 · Cellular and Molecular Gastroenterology and Hepatology
  83. When BRG1 Turns Off: Chromatin Remodeling and YAP Signaling Drive ITPN Progression
    Shigetsugu Takano, Masayuki Ohtsuka · 2025 · Cellular and Molecular Gastroenterology and Hepatology
  84. mSWI/SNF complex inhibition sensitizes KRAS-mutant lung cancers to targeted therapies via epithelial-mesenchymal subversion
    Claudia Gentile, William W. Feng, Sean M. Lenahan, Alexander Wang Ying, Daren C. Card, Florence T.H. Wu, Nhu‐An Pham, Nikolina Radulovich, Pinjiang Mary Cao, K. Hueniken et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  85. The role of Activin signaling pathway in the initiation and progression of pancreatic cancer
    Yajie Zhao · 2019 · theses.fr (ABES)
  86. Étude de la tumorigenèse pancréatique des tumeurs intracanalaires papillaires et mucineuses du pancréas (TIPMP)
    Diane Lorenzo · 2024 · theses.fr (ABES)
  87. Epigenetic Control of Spatiotemporal Dynamics of Pancreatic Cancer Cells via Brg1–Rac1 Signaling
    Akihisa Yamamoto, Akihisa Fukuda, Yuichi Fukunaga, Kentaro Hayashi, Hiroshi Seno, Motomu Tanaka · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  88. Loss of PBRM1 accelerates pancreatic cancer progression by inducing acquisition of mesenchymal phenotype and inflammatory cancer-associated fibroblasts reprogramming
    Jin Li, 阙日升, Jian Zhang, Ke Ma, Shouliang Guo, Liang Wen, Jianhui Zhao, Wen Chen, Xun Wang, Hao Qin et al. · 2026 · Cancer Letters
  89. Altered chromatin signaling in cancer
    Yusuke Okuda, Andrew Scott Liss · 2026 · Elsevier eBooks
  90. Chromatin remodeling and epigenetic reprogramming in chronic disease and cancer in the liver and pancreas
    Ateka Saleh, Karam Ghazal‐Aswad, M.G. Fernandez-Barrena, C.L. Pin · 2026 · Elsevier eBooks